NCT01880593View on ClinicalTrials.gov

Ketamine Plus Lithium in Treatment-Resistant Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Depression
Interventions
DRUG

Lithium

Subjects in this arm take 600-1200mg of Lithium pills at night for duration of the study.

DRUG

Ketamine

DRUG

Placebo

Subjects in this arm take placebo pills at night for duration of the study.

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT01880593 - Ketamine Plus Lithium in Treatment-Resistant Depression | Biotech Hunter | Biotech Hunter